Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients

RecruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Invasive Fungal Infection
Interventions
DEVICE

other antifungal agents,breathing machine

If treatment failure for patients in group A and group B,change other antifungal agents (Amphotericin B for Injection, 25mg, North China Pharmaceutical Co., Ltd or Caspofungin Acetate for lnjection,50mg and 70mg Cancidas®). Mechanical ventilation (EVITA 4, Dräger Medical Equipment (Shanghai) Co.,Ltd) was adopte.Treatment failure was defined as no improvement or worse of clinical symptoms, laboratory data, requiring change of antifungal agents therapy.

Trial Locations (1)

41

RECRUITING

Zhengzhou Central Hospital affiliated to Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

People's Hospital of Zhengzhou University

OTHER